1800-272-662
Shopping Cart 0
countryflagAU
Login

Im Cannabis Corp

Healthcare US IMCC

0.82USD
0.0058(0.71%)

Last update at 2026-03-11T14:24:00Z

Day Range

0.820.83
LowHigh

52 Week Range

0.191.35
LowHigh

Fundamentals

  • Previous Close 0.81
  • Market Cap8.14M
  • Volume1514
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-9.77300M
  • Revenue TTM48.80M
  • Revenue Per Share TTM3.81
  • Gross Profit TTM 9.16M
  • Diluted EPS TTM-0.81

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -26.05900M -18.01300M -28.47200M -7.32900M 3.37M
Minority interest 2.41M 0.76M 1.51M 1.45M 1.43M
Net income -24.92100M -18.51800M -28.73400M -7.41900M 1.68M
Selling general administrative 24.10M 39.69M 14.79M 9.10M 2.52M
Selling and marketing expenses 11.47M 8.99M 3.78M 1.24M 0.51M
Gross profit 9.16M 10.30M 10.47M 3.93M 4.20M
Reconciled depreciation 7.33M 5.73M 0.93M 0.60M -
Ebit -26.40700M -38.38900M -8.24500M -6.64300M 3.08M
Ebitda -12.37300M -10.63600M -7.03800M -2.38900M 3.26M
Depreciation and amortization 14.03M 27.75M 1.21M 4.25M 0.18M
Non operating income net other - - - - -
Operating income -26.40700M -38.38900M -8.24500M -6.64300M 3.08M
Other operating expenses 80.74M 92.69M 24.14M 15.72M 1.75M
Interest expense 1.97M 1.65M 20.50M 0.71M 0.08M
Tax provision -1.13800M 0.51M 0.26M 0.09M -
Interest income 6.70M 22.02M 0.28M 3.65M -
Net interest income 4.73M 20.38M -20.22700M 2.95M -0.00013M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -1.13800M 0.51M 0.26M 0.09M 0.74M
Total revenue 54.34M 54.30M 15.89M 9.07M 5.20M
Total operating expenses 35.57M 48.69M 18.71M 10.57M 2.74M
Cost of revenue 45.17M 44.00M 5.42M 5.14M 1.00M
Total other income expense net 0.35M 20.38M -20.22700M -0.68600M 0.28M
Discontinued operations -166.37900M -17.85400M -17.85400M -17.85400M -
Net income from continuing ops -24.92200M -18.51800M -28.73400M -7.41900M -0.12267M
Net income applicable to common shares - -17.76300M -28.69800M -7.29200M 1.68M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 48.81M 60.68M 287.39M 38.12M 30.89M
Intangible assets 5.79M 7.91M 30.89M 1.09M 0.89M
Earning assets - - - - -
Other current assets 0.21M 1.63M 2.30M 4.09M 0.05M
Total liab 35.11M 36.88M 82.44M 25.51M 4.79M
Total stockholder equity 14.47M 22.65M 201.24M 11.10M 24.66M
Deferred long term liab - - - - -
Other current liab 10.22M 8.42M 26.18M 2.76M 1.46M
Common stock 253.88M 245.78M 237.68M 37.04M 0.04M
Capital stock 253.88M 245.78M 237.68M 37.04M 0.04M
Retained earnings -249.14500M -238.91300M -50.74300M -33.00100M -4.27300M
Other liab - 1.59M 13.00M 18.41M 1.28M
Good will 10.11M 9.77M 121.30M 0.30M 0.30M
Other assets - 0.76M 0.03M 0.77M 0.09M
Cash 1.81M 2.45M 13.90M 8.88M 13.93M
Cash and equivalents - - - - -
Total current liabilities 32.81M 33.82M 51.23M 6.27M 2.61M
Current deferred revenue 0.79M 0.03M 0.14M 0.74M -
Net debt 11.97M 9.09M 15.37M -7.89500M -12.87600M
Short term debt 12.57M 10.06M 11.06M 0.17M 0.16M
Short long term debt 12.12M 9.25M 9.50M - -
Short long term debt total 13.78M 11.53M 29.27M 0.99M 1.05M
Other stockholder equity - 14.51M 11.69M 5.83M 28.58M
Property plant equipment - 6.75M 47.72M 6.27M 4.27M
Total current assets 24.27M 32.67M 84.31M 27.14M 24.29M
Long term investments 2.29M 2.41M 2.43M 2.34M 0.91M
Net tangible assets - 4.57M 48.34M 9.50M 23.32M
Short term investments - - 3.13M - -
Net receivables 11.33M 12.01M 33.90M 5.72M 2.06M
Long term debt 0.39M 0.40M 0.39M - -
Inventory 10.91M 16.59M 31.08M 8.45M 5.47M
Accounts payable 9.22M 15.31M 13.99M 2.60M 0.99M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 9.73M 1.28M 2.61M 1.23M 0.31M
Additional paid in capital - - - - -
Common stock total equity - - - 37.04M 0.04M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 5.79M - 0.01M - 1.42M
Deferred long term asset charges - - - - -
Non current assets total 24.55M 28.00M 203.08M 10.97M 6.60M
Capital lease obligations 1.27M 1.89M 19.37M 0.99M 1.05M
Long term debt total - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -1.13500M -1.40800M -9.01200M -1.34700M -0.91200M
Change to liabilities - 0.00000M 5.57M 2.13M 0.80M
Total cashflows from investing activities - -1.40800M -9.01200M -4.07500M -3.77500M
Net borrowings - - 7.17M -0.18200M -1.05300M
Total cash from financing activities 11.08M 4.76M 48.73M 6.74M 17.05M
Change to operating activities - 16.25M 9.95M 0.90M -1.92800M
Net income -9.49800M -191.30100M -18.51800M -28.73400M -7.41900M
Change in cash -0.63600M -11.45400M 5.02M -5.04100M 6.33M
Begin period cash flow 2.45M 13.90M 8.88M 13.93M 7.59M
End period cash flow 1.81M 2.45M 13.90M 8.88M 13.93M
Total cash from operating activities -9.73900M -12.64000M -34.37200M -7.91900M -5.95900M
Issuance of capital stock 2.27M 3.76M 28.13M 39.35M 15.57M
Depreciation 3.00M 7.33M 5.73M 0.93M 0.60M
Other cashflows from investing activities - - 0.02M -0.01800M -0.01800M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory 4.77M 1.45M -13.29500M -0.95800M 0.12M
Change to account receivables 3.62M 6.06M -6.60200M -3.53400M -1.63100M
Sale purchase of stock - - - - -
Other cashflows from financing activities 3.46M 7.64M 21.23M 6.92M 2.53M
Change to netincome - 134.44M -11.54800M 21.31M 2.95M
Capital expenditures 0.58M 1.56M 4.59M 2.71M 1.55M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.40M 34.48M -10.81800M -1.45700M -2.64200M
Stock based compensation 0.23M 3.77M 7.47M 3.38M 2.68M
Other non cash items -5.25900M 136.09M -18.51400M 18.03M 0.92M
Free cash flow -10.32000M -14.20200M -38.96700M -10.62900M -7.50600M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IMCC
Im Cannabis Corp		 0.0058 0.71% 0.82 - 16.31 0.18 0.77 0.35 -6.1494
ZTS
Zoetis Inc		 -1.16 0.96% 119.33 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.02 0.08% 25.62 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 5.77 4.51% 133.78 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.045 0.25% 18.16 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel.

Im Cannabis Corp

Kibbutz Glil Yam, Tel Aviv, Israel, 4690500

Key Executives

Name Title Year Born
Mr. Marc Lustig M.B.A., M.Sc. Exec. Chairman 1974
Mr. Oren Shuster CEO & Director NA
Mr. Shai Shemesh Chief Financial Officer NA
Mr. Michael Ruscetta Chief Exec. Officer of Trichome Financial Corp. 1969
Mr. Howard Steinberg C.F.A. Chief Exec. Officer of TJAC & MYM 1965
Advocate Yael Harrosh Chief Legal & Operations Officer NA
Mr. Richard Balla CEO & Director of German Operations ? Adjupharm GmbH NA
Ms. Rinat Efrima Chief Exec. Officer of Israel 1977
Mr. Marc Lustig M.B.A., M.Sc. Executive Chairman 1974
Mr. Uri Birenberg Chief Financial Officer 1976

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.